Published in J Prenat Med on April 01, 2011
Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report. BMC Nephrol (2014) 0.81
Neurological manifestations in patients with antiphospholipid syndrome. Iran J Neurol (2013) 0.75
Immunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome. Exp Ther Med (2016) 0.75
HELLP syndrome and its relation with the antiphospholipid syndrome. Blood Transfus (2013) 0.75
Combined spinal-epidural anesthesia in a mild thrombocytopenic patient with antiphospholipid antibody syndrome. Korean J Anesthesiol (2014) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ (2005) 5.96
Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med (2005) 5.94
The antiphospholipid syndrome. N Engl J Med (2002) 5.42
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum (2002) 5.12
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A (1990) 4.59
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet (2007) 3.53
Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol (2002) 3.51
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
The antiphospholipid syndrome: ten years on. Lancet (1993) 3.10
Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol (2006) 3.08
Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost (1995) 2.95
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med (1992) 2.63
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol (2009) 2.58
The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol (1989) 2.23
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2010) 2.05
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med (1997) 2.04
Recurrent miscarriage. Lancet (1990) 2.02
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med (2004) 1.95
Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet (1990) 1.92
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev (2005) 1.84
Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med (1994) 1.80
Haemostasis and pregnancy. Thromb Haemost (2006) 1.79
Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther (2006) 1.78
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol (2003) 1.76
Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest (1995) 1.75
High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus. Arch Intern Med (2004) 1.72
Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol (1993) 1.64
A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies. Fertil Steril (2003) 1.61
Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome. Obstet Gynecol (1997) 1.59
Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J (1999) 1.58
Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol (2000) 1.53
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum (2001) 1.53
Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol (1996) 1.51
Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol (1991) 1.49
A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol (2001) 1.46
Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol (1992) 1.44
The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant. J Thromb Haemost (2005) 1.43
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum (2005) 1.41
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) (2002) 1.40
Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann Rheum Dis (2008) 1.38
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood (2003) 1.37
Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol (1999) 1.35
Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv (1999) 1.33
Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood (2006) 1.29
Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost (2008) 1.29
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost (2009) 1.28
Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum (2005) 1.26
Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol (1992) 1.21
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood (2004) 1.19
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum (2009) 1.17
Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol (2004) 1.17
Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol (2003) 1.16
Antiphospholipid antibodies and cerebral ischemia in young people. Neurology (1990) 1.15
Treatment of pregnant patients with antiphospholipid syndrome. Lupus (2003) 1.13
Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med (1990) 1.13
Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. Hum Reprod (1997) 1.12
Antibody to cardiolipin, lupus anticoagulant, and fetal death. J Rheumatol (1987) 1.08
Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost (2002) 1.08
Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. J Immunol (2002) 1.08
Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod Immunol (2009) 1.08
Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb Haemost (2002) 1.08
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood (2007) 1.06
Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol (2007) 1.05
Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost (2005) 1.04
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Blood (2008) 1.03
Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol (2006) 1.03
Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol (2006) 1.02
Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent--the Nîmes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost (1999) 1.02
Should patients with venous thromboembolism be screened for thrombophilia? Am J Med (2008) 1.00
Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice. Circulation (1997) 0.99
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost (2005) 0.98
Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril (1996) 0.97
A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost (2005) 0.97
Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases. Arthritis Rheum (2007) 0.95
Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol (1995) 0.95
High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod (1995) 0.94
The role of complement in the antiphospholipid syndrome. Curr Dir Autoimmun (2004) 0.94
Antiphospholipid antibodies and the protein C pathway. J Autoimmun (2000) 0.94
Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost (2006) 0.93
Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol (2007) 0.93
Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum (1999) 0.93
Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus (2002) 0.92
Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost (2005) 0.92
A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol (1996) 0.92
Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod (1995) 0.92
Revision of the Sapporo criteria for the antiphospholipid syndrome-- coming to grips with evidence and Thomas Bayes? Thromb Haemost (2006) 0.90
Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Lupus (2007) 0.90
Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol (1993) 0.89
Calibrated automated thrombin generation in normal uncomplicated pregnancy. Thromb Haemost (2008) 0.89
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. J Bone Miner Res (2008) 1.00
Increased nuchal traslucency in normal karyotype fetuses. J Prenat Med (2011) 0.89
Update on systemic lupus erythematosus pregnancy. J Prenat Med (2010) 0.85
Fetal growth restriction: current perspectives. J Prenat Med (2011) 0.82
Maternal weight gain during pregnancy and neonatal birth weight: a review of the literature. J Prenat Med (2011) 0.82
Nonvisualization of fetal gallbladder: a case report and review of the literature. J Prenat Med (2010) 0.75
Treatment of gestational diabetes: oral hypoglycemic agents or insulin? J Prenat Med (2011) 0.75
Fetal cardiac function during the first trimester of pregnancy. J Prenat Med (2011) 0.75
First- and second-trimester ADAM12s in Down syndrome screening. Clin Chem (2010) 0.75